↓ Skip to main content

Dove Medical Press

Efficacy and Safety of Apatinib for Elderly Patients with Advanced or Metastatic Gastric Cancer After Failure of at Least First-Line Chemotherapy: A Multi-Center, Single-Arm, Phase II Study

Overview of attention for article published in OncoTargets and therapy, August 2021
Altmetric Badge

Mentioned by

video
1 YouTube creator

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
16 Mendeley
Title
Efficacy and Safety of Apatinib for Elderly Patients with Advanced or Metastatic Gastric Cancer After Failure of at Least First-Line Chemotherapy: A Multi-Center, Single-Arm, Phase II Study
Published in
OncoTargets and therapy, August 2021
DOI 10.2147/ott.s322710
Pubmed ID
Authors

Dengfeng Ren, Guoxiu Wang, Yu Zhang, Jie Kan, Qiuxia Dong, Junhui Zhao, Faxiang Ji, Hao Li, Yushuang Luo, Mingzhe Lin, Guoyuan Li, Zhibo Liu, Xinfu Ma, Qijing Guo, Fuxing Zhao, Guoshuang Shen, Jiuda Zhao

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 16 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 2 13%
Other 1 6%
Student > Doctoral Student 1 6%
Lecturer > Senior Lecturer 1 6%
Professor 1 6%
Other 3 19%
Unknown 7 44%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 3 19%
Medicine and Dentistry 3 19%
Nursing and Health Professions 2 13%
Chemical Engineering 1 6%
Unknown 7 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 August 2021.
All research outputs
#22,774,430
of 25,392,582 outputs
Outputs from OncoTargets and therapy
#2,080
of 3,016 outputs
Outputs of similar age
#378,977
of 440,771 outputs
Outputs of similar age from OncoTargets and therapy
#42
of 62 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,016 research outputs from this source. They receive a mean Attention Score of 2.9. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 440,771 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 62 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.